Showing 1 - 7 results of 7 for search 'J.E. Cortes', query time: 0.05s Refine Results
  1. 1
    Interacción entre vulcanismo, tectónica y sedimentación en una plataforma carbonatada somera: Ejemplo en el Tethys occidental (Jurásico Medio, sureste de la Cordillera Ibérica)

    Interacción entre vulcanismo, tectónica y sedimentación en una plataforma carbonatada somera: Ejemplo en el Tethys occidental (Jurásico Medio, sureste de la Cordillera Ibérica)... by J. E. Cortés

    Published 2020-06-01
    Get full text
    Article
  2. 2
    High-resolution molecular stratigraphy of Oligocene–Miocene sequence of Tumaco-1-ST-P well, Tumaco forearc Basin, Colombia

    High-resolution molecular stratigraphy of Oligocene–Miocene sequence of Tumaco-1-ST-P well, Tumaco forearc Basin, Colombia by J. E. Cortes, A. Mejía-Molina, C. A. Vargas, S. I. Cortes

    Published 2019-04-01
    Get full text
    Article
  3. 3
    P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL

    P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL by J. E. Cortes, D. Milojkovic, C. Gambacorti-Passerini, V. García-Gutiérrez, M. J. Mauro, E. Leip, S. Purcell, A. Viqueira, T. H. Brümmendorf

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY DIAGNOSED NPM1-MUTATED AML

    P525: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF ENTOSPLETINIB ADDED TO INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN NEWLY D... by J. C. Byrd, J. E. Cortes, M. D. Minden, T. Oellerich, E. M. Stein, J. Elder, P. Kumar, G. Bray, J. DiMartino, W. Stock

    Published 2022-06-01
    Get full text
    Article
  5. 5
    FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)

    FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML) by J.E. Lancet, T.L. Lin, D. Hogge, S.R. Solomon, G.J. Schiller, M.J. Wieduwilt, R. Martin, S. Faderl, Y. Chang, J.E. Cortes

    Published 2020-11-01
    Get full text
    Article
  6. 6
    P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL

    P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY... by T. Hughes, J. E. Cortes, D. Réa, M. J. Mauro, A. Hochhaus, D.-W. Kim, K. Sasaki, F. Lang, M. C. Heinrich, M. Breccia, M. Deininger, Y.-T. Goh, J. J. Janssen, M. Talpaz, V. Gómez García de Soria, P. le Coutre, S. Kapoor, S. Cacciatore, F. Polydoros, N. Agrawal, F.-X. Mahon

    Published 2022-06-01
    Get full text
    Article
  7. 7
    S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE

    S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE... by D. Rea, A. Hochhaus, M. J. Mauro, Y. Minami, E. Lomaia, S. Voloshin, A. Turkina, D.-W. Kim, J. F. Apperley, J. E. Cortes, A. Abdo, L. M. Fogliatto, D. D. H Kim, P. le Coutre, S. Saussele, M. Annunziata, T. P. Hughes, N. Chaudhri, L. Chee, V. García-Gutiérrez, K. Sasaki, S. Kapoor, A. Allepuz, S. Quenet, V. Bédoucha, C. Boquimpani

    Published 2022-06-01
    Get full text
    Article

Search Tools: